XML 98 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings per Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Basic and diluted earnings per share
Basic and diluted shares outstanding used in our earnings per share calculation are calculated as follows:
 For the Years Ended December 31,
(In millions)202120202019
Numerator:
Net income attributable to Biogen Inc.$1,556.1 $4,000.6 $5,888.5 
Denominator:
Weighted average number of common shares outstanding149.1 160.9 187.1 
Effect of dilutive securities:
Time-vested restricted stock units0.3 0.2 0.2 
Market stock units0.1 0.1 0.1 
Performance stock units settled in stock0.1 0.1 — 
Dilutive potential common shares0.5 0.4 0.3 
Shares used in calculating diluted earnings per share149.6 161.3 187.4